Literature DB >> 15454270

Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases.

Michael Aviram1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15454270     DOI： 10.1016/j.freeradbiomed.2004.07.009

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN： 0891-5849            Impact factor:   7.376


× No keyword cloud information.
  9 in total

1.  Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy.

Authors:  Hande Koksal; Sevil Kurban
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

2.  Modulation of paraoxonase 1 and 3 expression after moderate exercise training in the rat.

Authors:  Rita Romani; Gianna Evelina De Medio; Simona di Tullio; Rosa Lapalombella; Irene Pirisinu; Vittoria Margonato; Arsenio Veicsteinas; Marina Marini; Gabriella Rosi
Journal:  J Lipid Res       Date:  2008-12-16       Impact factor: 5.922

3.  The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients.

Authors:  Zeynep Tartan; Gokcen Orhan; Hulya Kasikçioglu; Huseyin Uyarel; Sennur Unal; Nihat Ozer; Batuhan Ozay; Figen Ciloglu; Nese Cam
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

4.  Effects of improved fat meat products consumption on emergent cardiovascular disease markers of male volunteers at cardiovascular risk.

Authors:  Paloma Celada; Francisco J Sánchez-Muniz; Gonzalo Delgado-Pando; Sara Bastida; Manuel Espárrago Rodilla; Francisco Jiménez-Colmenero; Begoña Olmedilla-Alonso
Journal:  J Physiol Biochem       Date:  2016-07-04       Impact factor: 4.158

5.  Regulatory regions of the paraoxonase 1 (PON1) gene are associated with neovascular age-related macular degeneration (AMD).

Authors:  Jadwiga Oczos; Christian Grimm; Daniel Barthelmes; Florian Sutter; Moreno Menghini; Barbara Kloeckener-Gruissem; Wolfgang Berger
Journal:  Age (Dordr)       Date:  2012-09-07

Review 6.  Potential Anti-Atherosclerotic Properties of Astaxanthin.

Authors:  Yoshimi Kishimoto; Hiroshi Yoshida; Kazuo Kondo
Journal:  Mar Drugs       Date:  2016-02-05       Impact factor: 5.118

7.  Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats.

Authors:  Yen-Cheng Chen; Ching-Chun Ho; Chih-Hsun Yi; Xiu-Zhu Liu; Tzu-Ting Cheng; Chen-Fuh Lam
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

8.  Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits.

Authors:  Paula R Augusti; Andréia Quatrin; Sabrina Somacal; Greicy Mm Conterato; Rocheli Sobieski; Amanda R Ruviaro; Luana H Maurer; Marta Mf Duarte; Miguel Roehrs; Tatiana Emanuelli
Journal:  J Clin Biochem Nutr       Date:  2012-06-08       Impact factor: 3.114

9.  Paraoxonase 1 activity and phenotype distribution in premenopausal and postmenopausal women.

Authors:  Dražan Butorac; Ivana Celap; Sanja Kačkov; Vera Robić; Tomislav Miletić; Zlata Flegar Meštrić; Andrea Hulina; Krunoslav Kuna; Tihana Žanić Grubišić; Marija Grdić Rajković
Journal:  Biochem Med (Zagreb)       Date:  2014-06-15       Impact factor: 2.313
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.